Waist-to-Hip Ratio Has Strongest Link With All-Cause Mortality
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 25, 2023 -- Waist-to-hip ratio (WHR) has a strong, consistent association with all-cause mortality, regardless of body mass index (BMI), according to a study published online Sept. 20 in JAMA Network Open.
Irfan Khan, from the David Braley Cardiac, Vascular, and Stroke Research Institute in Hamilton, Ontario, Canada, and colleagues examined which of BMI, fat mass index (FMI), and WHR has the strongest and most consistent association with mortality in a cohort study using incident deaths from the U.K. Biobank (UKB; 2006 to 2022). A total of 387,672 UKB participants of British White ancestry were divided into a discovery and validation cohort (337,078 and 50,594, respectively), with the latter including 25,297 deaths and 25,297 controls.
The researchers observed J-shaped associations for measured BMI and FMI with all-cause mortality, while the association of WHR with all-cause mortality was found to be linear using the hazard ratio scale (hazard ratio per standard deviation [SD] increase of WHR, 1.41). A stronger association was seen for genetically determined WHR with all-cause mortality than for BMI (odds ratio per SD increase of WHR, 1.51; odds ratio per SD increase of BMI, 1.29). Compared with women, men had a stronger association (odds ratio, 1.89). The genetically determined WHR-all-cause mortality association was consistent, regardless of observed BMI, unlike BMI and FMI.
"Our results provide further support to shift public health focus from measures of general adiposity, such as BMI, to adiposity distribution using WHR," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.